Muscle derived cells-urethral sphincter repair

Unassigned

New Medicines

Stress incontinence - in women

Information

Advanced therapy medicinal product (ATMP)
Cook MyoSite
Cook MyoSite

Development and Regulatory status

Phase III Clinical Trials
Phase III Clinical Trials
Phase III Clinical Trials

Category

Autologous stem cell-based therapy derived from skeletal muscle biopsies
UK prevalence rates of urinary incontinence are between 5-69% in women
Stress incontinence - in women
Bladder instillation

Trial or other data

Dec 19 · UK trial sites; NCT03104517 (Plymouth) [7]

Evidence based evaluations